Study on the biomechanical mechanism of Mawangdui guidance in the treatment of nonspecific low back pain

Scientific research project of Sichuan Cadre Health Department (Chuanganyan2020-501)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041080

Enrollment

Unknown

Registered

2020-12-17

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonspecific low back pain

Interventions

Drug therapy group:Take selehib by mouth

Mawangdui guidance group:Practice your health regimen

Eligibility

Sex/Gender

All

Age

20 Years to 39 Years

Inclusion criteria

Inclusion criteria: (1) Patients who can meet CNLBP diagnostic criteria; (2) course of disease > 12 weeks; (3) 20-39 years old, able to cooperate actively; (4) patients who have never received any standardized conservative treatment or surgical treatment before and have no congenital deformity of the lumbar spine; (5) The participants know the relevant information of this study, and they are willing to and have completed the relevant informed consent

Exclusion criteria

Exclusion criteria: (1) Diseases affecting the musculoskeletal system, such as intervertebral disc herniation, spinal fractures, severe arthritis, osteopathic spinal stenosis, ankylosing spondylitis, etc.; (2) Patients with substantial damage to other important organs, such as severe heart, liver, kidney, lung dysfunction and cardiovascular and cerebrovascular diseases; (3) Patients with low back pain caused by diseases of urinary system were diagnosed clearly (4) The course of the disease is not more than 12 weeks of acute low back pain attack period of patients (5) Patients who are prone to co-infection and bleeding, tumors, pregnant women, and patients with postoperative dysfunction; (6) In the recent three months, patients received acupuncture, massage, application, fumigation and other characteristics of Traditional Chinese medicine treatment; (7) Persons with previous mental illness or long-term use of sedatives. (Note: Patients who meet any of the above criteria are excluded)

Design outcomes

Primary

Measure	Time frame
Bioelectrical signal conduction time;Isokinetic muscle strength test;	—

Secondary

Measure	Time frame
JOA score;ODI scale;The Jane McGee Pain Questionnaire;	—

Countries

China

Contacts

Public ContactZhang Guilong

Hospital of Chengdu University of Traditional Chinese Medicine

10308626@qq.com+86 18180608848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026